Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

CARMINA, Enrico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.353
EU - Europa 3.161
AS - Asia 2.689
SA - Sud America 433
Continente sconosciuto - Info sul continente non disponibili 149
AF - Africa 87
OC - Oceania 22
Totale 13.894
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.242
SG - Singapore 868
RU - Federazione Russa 711
CN - Cina 610
IT - Italia 598
UA - Ucraina 427
BR - Brasile 316
HK - Hong Kong 313
DE - Germania 289
FI - Finlandia 289
VN - Vietnam 268
GB - Regno Unito 202
PL - Polonia 165
IE - Irlanda 164
FR - Francia 136
BD - Bangladesh 130
JP - Giappone 119
KR - Corea 106
SE - Svezia 53
IN - India 47
TR - Turchia 47
CA - Canada 46
MX - Messico 31
CO - Colombia 28
NL - Olanda 28
AR - Argentina 26
IQ - Iraq 23
CI - Costa d'Avorio 22
ZA - Sudafrica 22
AU - Australia 19
RO - Romania 19
BE - Belgio 18
PK - Pakistan 18
VE - Venezuela 17
EC - Ecuador 16
SA - Arabia Saudita 15
AT - Austria 14
PH - Filippine 13
ES - Italia 12
NP - Nepal 12
IR - Iran 11
ID - Indonesia 10
MY - Malesia 10
UZ - Uzbekistan 10
CL - Cile 9
BO - Bolivia 8
EU - Europa 8
MA - Marocco 8
CR - Costa Rica 7
DZ - Algeria 7
JM - Giamaica 7
KE - Kenya 7
UY - Uruguay 7
CH - Svizzera 6
TN - Tunisia 6
AZ - Azerbaigian 5
JO - Giordania 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
EE - Estonia 4
PS - Palestinian Territory 4
PY - Paraguay 4
EG - Egitto 3
IL - Israele 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LB - Libano 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
OM - Oman 3
PA - Panama 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GR - Grecia 2
LK - Sri Lanka 2
LT - Lituania 2
LY - Libia 2
MM - Myanmar 2
MT - Malta 2
NG - Nigeria 2
PE - Perù 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BM - Bermuda 1
BN - Brunei Darussalam 1
Totale 13.735
Salva come PNG Salva come JPEG
Città #
Ashburn 892
Fairfield 793
Singapore 577
San Jose 473
Woodbridge 421
Houston 368
Chandler 364
Seattle 334
Hong Kong 300
Wilmington 292
Cambridge 259
Jacksonville 228
Ann Arbor 190
Palermo 175
Dublin 161
Zgierz 151
Santa Clara 141
Frankfurt am Main 123
Medford 122
Tokyo 117
Council Bluffs 108
Moscow 101
Nanjing 82
Princeton 78
Ho Chi Minh City 76
Altamura 75
Beijing 70
Los Angeles 70
Hanoi 69
Lauterbourg 68
Lawrence 62
Tulsa 62
Boardman 60
Dearborn 59
San Diego 52
New York 51
Seongnam 50
Dallas 43
Chicago 40
Hefei 40
Milan 38
Buffalo 33
Des Moines 33
Shenyang 32
São Paulo 31
The Dalles 31
Nanchang 29
Helsinki 26
Columbus 24
Hebei 23
Izmir 23
Abidjan 22
London 22
Jiaxing 21
Atlanta 20
Changsha 20
Zhengzhou 18
Brooklyn 17
Brussels 17
Jinan 17
San Paolo di Civitate 16
Da Nang 15
Orem 15
Rio de Janeiro 15
Rome 15
Tianjin 15
Washington 15
Amsterdam 14
Guangzhou 14
Haiphong 14
Montreal 14
Saint Petersburg 14
Ludwigshafen am Rhein 13
Auburn Hills 12
Belo Horizonte 12
Verona 12
Las Vegas 11
Denver 10
North Bergen 10
Nuremberg 10
Phoenix 10
Seoul 10
Warsaw 10
Baghdad 9
Bogotá 9
Cardiff 9
City of London 9
Falls Church 9
Memphis 9
Ningbo 9
Queens 9
Redwood City 9
Tashkent 9
Dhaka 8
Honolulu 8
Kilburn 8
Kingston 8
Kumar 8
Miami 8
Philadelphia 8
Totale 8.736
Salva come PNG Salva come JPEG
Nome #
High prevalence of polycystic ovary syndrome in women with mild hirsutism and no other significant clinical symptoms 409
Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. 329
Hypogonadism and hormone replacement therapy on bone mass of Adult Women with Thalassemia Major 256
A 20-year follow-up of young women with Polycystic Ovary Syndrome 250
Does the level of serum antimüllerian hormone predict ovulatory function in women with polycystic ovary syndrome with aging? 242
Atherogenic forms of dyslipidemia in women with polycystic ovary syndrome 236
Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in Southern Italy than in USA and the influence of criteria for the diagnosis of PCOS 234
Low serum levels of 25-hydroxy vitamin D in adults affected by thalassemia major or intermedia. 234
Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis 232
Correlation between deficienty of 25 (oh) vitamin D and liver damage in adult talassemic subjects 230
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report 219
Prospective parallel randomized double-blind double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first line treatment for ovulation induction in non-obese anovulatory women with polycystic ovary syndrome 214
-Correlation between deficiency of 25 (OH) vitamin D and liver damage in adult talassemic subjects 212
Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society 212
Bone turnover markers in postmenopausal womens treated with alendronate or risedronate: differences in early dynamics 210
Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome 207
PHENOTYPIC VARIATION IN HYPERANDROGENIC WOMEN INFLUENCES THE FINDINGS OF ABNORMAL METABOLIC AND CARDIOVASCULAR RISK PARAMETERS. 206
Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome. 206
Reproductive outcome of women with 21-hydroxylase deficient non-classic adrenal hyperplasia 206
The malnutrition in the elderly: a clinical approach. 205
Consensus on women's health aspects of polycystic ovary syndrome (PCOS) 203
Body composition of individuals with polycystic ovary syndrome 203
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group 202
Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome 202
Uterine effects of metformin administration in anovulatory women with polycystic ovary sindrome 199
Assessment of cardiovascular risk and prevention of cardiovascular disease in women with Polycystic Ovary Syndrome: a consensus statement of the Androgen Excess and PCOS (AE-PCOS) Society 196
OVARIAN AND ADRENAL HYPERANDROGENISM 195
Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin and ghrelin 194
Androgen excess and cardiovascular risk. 194
Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome 193
Cardiovascular risk and events in polycystic ovary syndrome 190
Diagnosis, Phenotype and Prevalence of Polycystic Ovary Syndrome 188
Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes 187
Correlation between deficiency of 25 (OH)-vitamin D, bone mineral density and markers of bone turnover in sicilian postmenopausal womens 186
Influence of sociocultural factors on the ovulatory status of polycystic ovary syndrome. 182
Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors 181
Lifecycle of Polycystic Ovary Syndrome (PCOS): From In Utero to Menopause 178
Evidence for altered adipocyte function in polycystic ovary syndrome 176
Correlates of increased lean muscle mass in women with polycystic ovary syndrome 176
Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndrome 175
The importance of diagnosing the Polycystic Ovary Syndrome 174
Does metformin induce ovulation in normoandrogenic anovulatory women? 172
The spectrum of androgen excess disorders 172
Obesity, Adipokines and Metabolic Syndrome in Polycystic Ovary Syndrome 172
Correlation between deficiency of 25 (OH) vitamin D, bone mineral density and markers of bone turnover in sicialian postmenopausal womens 171
Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines 171
Mullarian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin-B 170
Ovarian size and blood flow in women with polycystic ovary syndrome (PCOS) and their correlations with some endocrine parameters 169
Differences in early dynamics of serum bone markers in women with postmenopausal osteoporosiseated by alendronate or risedronate 165
Metabolic and cardiopulmonary effects of detraining after a structured exercise training programme in young PCOS women 165
Low circulating levels of HDL-cholesterol in women with PCOS and no other lipid abnormalities are associated to increased carotid intima media thickness and finding of atherogenic plaques. 162
Need for liver evaluation in polycystic ovary syndrome 161
Differences in early dynamics of serum bone markers in women with postmenopausal osteoporosis treated by alendronate or risedronate 158
The diagnosis of polycystic ovary syndrome in adolescents 157
Introduction to the special issue: 2012 AE-PCOS meeting 156
Not all women diagnosed with PCOS share the same cardiovascular risk profiles 154
Statins and osteoporosis: myth or reality? 149
Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype 146
Birth weight in polycystic ovary syndrome: correlation with adult insulin sensitivity. 145
Position statement: criteria for defining Polycystic Ovary Syndrome as predominantly hyperandrogenic syndrome: an androgen excess society guideline 145
How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome? 143
Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. 140
Elevated levels of non-HDL-cholesterol are relatively uncommon in women with PCOS and generally reflect LDL-cholesterol levels. 139
Non-classic forms of atherogenic dyslipidemia in women with polycystic ovary syndrome. 135
Fat distribution in idiopathic hyperandrogenism. 133
Long-term consequences of polycystic ovary syndrome on cardiovascular risk 132
Endothelial abnormalities in young women with PCOS: correlations with insulin resistance and decreased levels of serum adiponectin 131
Editorial 131
Role of hypogonadism in development of bone alterations in thalassemic patients 130
When periods stop: cardiovascular consequences of PCOS. 130
Increasing adiposity in normal ovulatory women affects adipocytokine expression in subcutaneous and visceral abdominal fat 130
Metabolic Syndrome in Polycystic Ovary Syndrome 128
Estroprogestins and cardiovascular risk in Polycystic Ovary Syndrome 117
In PCOS women AMH circulating levels predict patients who become ovulatory with aging. 110
Milder forms of atherogenic dyslipidemia in ovulatory vs. anovulatory polycystic ovary syndrome phenotype. 106
PCOS: metabolic impact and long-term management 89
La somministrazione di amfotericina B per via endoarteriosa rappresenta una valida e sicura terapia della mucormicosi 87
Totale 13.894
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.664
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.664
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022564 0 0 0 22 26 26 61 39 86 82 55 167
2022/2023991 116 224 13 101 126 151 15 81 114 5 38 7
2023/2024388 14 80 27 88 37 70 25 13 1 8 5 20
2024/20251.280 30 139 91 127 50 27 59 94 72 132 148 311
2025/20264.198 254 93 205 200 266 558 552 405 336 956 186 187
2026/20271.115 144 134 693 144 0 0 0 0 0 0 0 0
Totale 13.894